Clinical presentation and monitoring of lupus nephritis.

作者: J E Balow

DOI: 10.1191/0961203305LU2055OA

关键词:

摘要: The diversity of clinical presentations lupus nephritis parallel the pathologic lesions seen in kidneys patients with SLE. Renal manifestations range from asymptomatic hematuria or proteinuria to overt nephritic and nephrotic syndromes, rapidly progressive glomerulonephritis, chronic renal failure. Subclinical nephropathy both during presentation monitoring disease activity is frequently missed because notorious unreliability routine screening urinalyses performed high-throughput pathology laboratories. Requisitions for urine microscopy should be flagged special attention at risk nephritis. Depression classic complement pathway components high titers anti-DNA, anti-nucleosome, anti-Clq antibodies identify are increased involvement flares Several damage indexes available, but they mostly used research setting none has achieved wide use standard practice.

参考文章(16)
Brad C Astor, Lisa Christopher-Stine, Derek Fine, Michelle Petri, Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. The Journal of Rheumatology. ,vol. 31, pp. 1557- 1559 ,(2004)
Stephen M. Korbet, Edmund J. Lewis, Melvin M. Schwartz, Morris Reichlin, Joni Evans, Richard D. Rohde, Factors predictive of outcome in severe lupus nephritis American Journal of Kidney Diseases. ,vol. 35, pp. 904- 914 ,(2000) , 10.1016/S0272-6386(00)70262-9
G. G. Illei, K. Takada, D. Parkin, H. A. Austin, M. Crane, C. H. Yarboro, E. M. Vaughan, T. Kuroiwa, C. L. Danning, J. Pando, A. D. Steinberg, M. F. Gourley, J. H. Klippel, J. E. Balow, D. T. Boumpas, Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis & Rheumatism. ,vol. 46, pp. 995- 1002 ,(2002) , 10.1002/ART.10142
H. Bootsma, P. Spronk, G. de Boer, P. Limburg, C. Kallenberg, R. Derksen, J. Wolters-Dicke, F. Gmelig-Meyling, L. Kater, J. Hermans, Prevention of relapses in systemic lupus erythematosus. The Lancet. ,vol. 345, pp. 1595- 1599 ,(1995) , 10.1016/S0140-6736(95)90114-0
Majid Rasoulpour, Inability of Community-Based Laboratories to Identify Pathological Casts in Urine Samples Archives of Pediatrics & Adolescent Medicine. ,vol. 150, pp. 1201- 1204 ,(1996) , 10.1001/ARCHPEDI.1996.02170360091015
Andrew S Levey, Josef Coresh, Ethan Balk, Annamaria T Kausz, Adeera Levin, Michael W Steffes, Ronald J Hogg, Ronald D Perrone, Joseph Lau, Garabed Eknoyan, None, NATIONAL KIDNEY FOUNDATION PRACTICE GUIDELINES FOR CHRONIC KIDNEY DISEASE: EVALUATION, CLASSIFICATION, AND STRATIFICATION Annals of Internal Medicine. ,vol. 139, pp. 137- 147 ,(2003) , 10.7326/0003-4819-139-2-200307150-00013
V Strand, D Gladman, D Isenberg, M Petri, J Smolen, P Tugwell, Endpoints: consensus recommendations from OMERACT IV Lupus. ,vol. 9, pp. 322- 327 ,(2000) , 10.1191/096120300678828424
Eng M. Tan, Alan S. Cohen, James F. Fries, Alfonse T. Masi, Dennis J. Mcshane, Naomi F. Rothfield, Jane Green Schaller, Norman Talal, Robert J. Winchester, The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis & Rheumatism. ,vol. 25, pp. 1271- 1277 ,(1982) , 10.1002/ART.1780251101